AccessPak for HIV PEP Expanded with Kaletra and Ipilimumab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Ipilimumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: ipilimumab
Brand name: Yervoy
Synonyms: Ipilimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-IPlex
- AccessPak for HIV PEP Expanded with Kaletra-Ipol
- AccessPak for HIV PEP Expanded with Kaletra-Ipratropium
- AccessPak for HIV PEP Expanded with Kaletra-Ipratropium (Oral Inhalation)
- AccessPak for HIV PEP Expanded with Kaletra-Ipratropium and Albuterol
- AccessPak for HIV PEP Expanded with Kaletra-Ipratropium and Albuterol Inhalation Solution
- Ipilimumab Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Ipilimumab Intravenous-Accolate
- Ipilimumab Intravenous-Accretropin
- Ipilimumab Intravenous-Accucaine
- Ipilimumab Intravenous-AccuHist Drops
- Ipilimumab Intravenous-AccuHist PDX Drops